Search

everythinglearnresearchcommunity

for

Search:↓

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Obese women with PCOS are more likely to have fatty liver disease.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Larger ovarian size is linked to higher insulin resistance in women with PCOS.

The document concludes that low-dose oral contraceptives and hormonal therapies can manage perimenopause symptoms and reduce some health risks, but lifestyle changes and disease screening are also important.

Type 2 diabetes may increase the risk of severe hair loss in African American women.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Women with PCOS are more likely to have sleep apnea, mainly if they are obese.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Blood removal and birth control pills both helped with hormone levels in women with PCOS, but birth control was better for regular periods and blood removal had fewer side effects.

Women with PCOS often have more belly fat and higher insulin levels, but belly fat isn't the only cause of their insulin resistance.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Hormonal changes after childbirth and menopause can lead to women's hair loss and facial hair growth, with a need for better treatments.

Women experience various skin issues at different life stages, requiring careful treatment and awareness.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

Women with irregular periods have a higher risk of heart disease.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Menopause affects hair and skin; more research needed for treatment.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Men and women experience skin aging differently due to changes in sex hormone levels with age.